Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
1,910,925
-
Shares change
-
-264,551
-
Total reported value, excl. options
-
$55,213,090
-
Value change
-
-$8,773,853
-
Number of buys
-
18
-
Number of sells
-
-42
-
Price
-
$28.90
Significant Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q2 2022
86 filings reported holding IDNA - ISHARES TR - GENOMICS IMMUN as of Q2 2022.
ISHARES TR - GENOMICS IMMUN (IDNA) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,910,925 shares
.
Largest 10 shareholders include Wharton Business Group, LLC (299,875 shares), Wealthcare Advisory Partners LLC (207,039 shares), MORGAN STANLEY (161,670 shares), UBS Group AG (155,796 shares), BANK OF AMERICA CORP /DE/ (149,841 shares), JANE STREET GROUP, LLC (104,417 shares), LPL Financial LLC (76,267 shares), ROYAL BANK OF CANADA (65,815 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (62,142 shares), and Kestra Advisory Services, LLC (51,021 shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.